Treatment with AKL1 in Obstructive Airways Disease (TAKL) Study [An Investigation of the Safety and Efficacy of Oral AKL1 in Patients Diagnosed with Obstructive Lung Disease]

  • Wilson, Andrew (Principal Investigator)
  • Sexton, Darren (Co-Investigator)

Project Details

StatusFinished
Effective start/end date1/02/09 → 31/12/13

Funding

  • International Primary Care Respiratory Group: £270,811.00